Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery

European Journal of Cardio-thoracic Surgery

Volumn 51, Issue 4, 2017, Pages 633-637

  Hansson, Emma C ^a,b   Malm, Carl Johan ^a,b   Hesse, Camilla ^a   Bjorn Hornestam ^a   Dellborg, Mikael ^a,b   Rexius, Helena ^a   Jeppsson, Anders ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Acute coronary syndrome; Cardiac surgery; Platelet aggregation inhibitors; Platelet function test; Platelet transfusion

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOCYTE CONCENTRATE; TICAGRELOR; ADENOSINE; ANTITHROMBOCYTIC AGENT; PURINERGIC P2Y RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CLINICAL ARTICLE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY SURGERY; CORONARY CARE UNIT; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG WITHDRAWAL; DUAL ANTIPLATELET THERAPY; EX VIVO STUDY; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL PATIENT; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; TREATMENT DURATION; ANALOGS AND DERIVATIVES; BLOOD CLOTTING PARAMETERS; CORONARY ARTERY BYPASS GRAFT; DRUG ADMINISTRATION; DRUG EFFECTS; MIDDLE AGED; PHYSIOLOGY; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PROCEDURES; THROMBOCYTE; TREATMENT WITHDRAWAL;

ADENOSINE; AGED; BLOOD PLATELETS; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PLATELET TRANSFUSION; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; WITHHOLDING TREATMENT;

EID: 85017368882     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezw373     Document Type: Article

References (22)

1. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
2. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57.
3. Becker RC, Bassand JP, Budaj A, Wojdyla DM, James SK, Cornel JH et al. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J 2011;32:2933-44.
4. Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, Falk V et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2014;46:517-92.
5. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/ non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:e179-347. [WorldCat]
6. Wallentin L. P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J 2009;30:1964-77.
7. Gurbel PA, Bliden KP, Butler K, Tantry US, Gesheff T, Wei C et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009;120:2577-85.
8. Price MJ, Walder JS, Baker BA, Heiselman DE, Jakubowski JA, Logan DK et al. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial. J Am Coll Cardiol 2012;59:2338-43.
9. Di Dedda U, Ranucci M, Baryshnikova E, Castelvecchio S; Surgical and Clinical Outcome Research Group. Thienopyridines resistance and recovery of platelet function after discontinuation of thienopyridines in cardiac surgery patients. Eur J Cardiothorac Surg 2014;45:165-170.
10. Hansson EC, Shams Hakimi C, Astrom-Olsson K, Hesse C, Wallen H, Dellborg M et al. Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor. Br J Anaesth 2014;112:570-5.
11. O'Connor SA, Amour J, Mercadier A, Martin R, Kerneis M, Abtan J et al. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study. Circ Cardiovasc Interv 2015;8:e002786.
12. Bonhomme F, Bonvini R, Reny JL, Poncet A, Fontana P. Impact of noninhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: an ex vivo study. Platelets 2015;26:324-30.
13. Martin AC, Berndt C, Calmette L, Philip I, Decouture B, Gaussem P et al. The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: an in-vitro study. Eur J Anaesthesiol 2016;33:361-7.
14. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006;96:781-8.
15. Ranucci M, Colella D, Baryshnikova E, Ranucci M, Colella D, Baryshnikova E et al.; Surgical and Clinical Outcome Research (SCORE) Group. Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery. Br J Anaesth 2014;113:970-6.
16. Ranucci M, Baryshnikova E, Soro G, Ballotta A, De Benedetti D, Conti D; Surgical and Clinical Outcome Research (SCORE) Group. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg 2011;91:123-9.
17. Malm CJ, Hansson EC,Akesson J, Andersson M, Hesse C, Shams Hakimi C et al. Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients. Br J Anaesth 2016;117:309-15.
18. Hansson EC, Jideus L, Aberg B, Bjursten H, Dreifaldt M, Holmgren A et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J 2016;37:189-97.
19. Nylander S, Mattsson C, Ramstrom S, Lindahl TL. Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombininduced human platelet activation. Br J Pharmacol 2004;142:1325-31.
20. Shams Hakimi C, Hesse C, Wallen H, Boulund F, Grahn A, Jeppsson A. In vitro assessment of platelet concentrates with multiple electrode aggregometry. Platelets 2015;26:132-7.
21. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008;99:121-6.
22. Paniccia R, Antonucci E, Maggini N, Miranda M, Gori AM, Marcucci R et al. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients. Thromb Haemost 2010;104:287-92.